Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
60 participants
INTERVENTIONAL
2024-01-01
2024-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Hypotheses of the Research H01: The education given to caregivers of Alzheimer's patients registered to home health services does not affect the caregivers' level of knowledge about Alzheimer's disease.
H11: The education given to caregivers of Alzheimer's patients registered to home health services increases the caregivers' level of knowledge about Alzheimer's disease.
H02: The education given to caregivers of Alzheimer's patients registered to home health services does not affect the caregivers' attitudes towards Alzheimer's disease.
H12: The education given to caregivers of Alzheimer's patients registered to home health services positively affects the caregivers' attitudes towards Alzheimer's disease.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Within the scope of the research, caregivers will be given face-to-face training in 2 sessions, 15 days apart.
Within the scope of the research, caregivers will be given face-to-face training in 2 sessions, 15 days apart.
They will receive routine home health care follow-up.
Control
They will receive routine home health care follow-up.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Within the scope of the research, caregivers will be given face-to-face training in 2 sessions, 15 days apart.
They will receive routine home health care follow-up.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Caring for a patient diagnosed with Alzheimer's disease for at least 6 months,
* Ages 18 and over,
* The one who is literate,
* Open to communication and collaboration,
* Caregivers who volunteer to participate in the study will be included in the study.
Exclusion Criteria
* Those with mental and cognitive retardation and
* Caregivers who do not want to continue the research will be excluded from the research.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hacer Gok Ugur
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hacer GÖK Uğur, Asoss.Prof.
Role: PRINCIPAL_INVESTIGATOR
Ordu Univercity
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hacer GÖK UĞUR
Ordu, Cumhuriyet Campus, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ordu123456
Identifier Type: -
Identifier Source: org_study_id